RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
+46.61%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$7.86B
AUM Growth
+$1.46B
(+23%)
Cap. Flow
+$280M
Cap. Flow
% of AUM
3.56%
Top 10 Holdings %
Top 10 Hldgs %
51.1%
Holding
83
New
21
Increased
18
Reduced
5
Closed
7
Top Buys
| 1 |
Edgewise Therapeutics
EWTX
|
$163M |
| 2 |
Dyne Therapeutics
DYN
|
$141M |
| 3 |
Evolent Health
EVH
|
$105M |
| 4 |
LENZ
LENZ Therapeutics
LENZ
|
$93.3M |
| 5 |
LBPH
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
|
$71M |
Top Sells
| 1 |
IMGN
Immunogen Inc
IMGN
|
$704M |
| 2 |
CBAY
Cymabay Therapeutics
CBAY
|
$164M |
| 3 |
ICVX
Icosavax, Inc. Common Stock
ICVX
|
$94M |
| 4 |
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
|
$93.6M |
| 5 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$73.2M |
Sector Composition
| 1 | Healthcare | 99.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
NewAmsterdam Pharma Company N.V. Warrant
NAMSW
$64M
| $3.68M | 0.05% |
333,333
| – | – |
|
|
IMGN
77
DELISTED
Immunogen Inc
IMGN
| – | – |
-23,750,601
| Closed | -$704M |
|
|
HARP
78
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| – | – |
-1,500,000
| Closed | -$17.1M |
|
|
CNTB
79
Connect Biopharma Holdings Limited Ordinary Shares
CNTB
$111M
| – | – |
-3,062,871
| Closed | -$3.61M |
|
80
SAB Biotherapeutics
SABS
$21.6M
| – | – |
-237,408
| Closed | -$1.63M |
|
|
ALPN
81
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| – | – |
-4,909,763
| Closed | -$93.6M |
|
|
CBAY
82
DELISTED
Cymabay Therapeutics
CBAY
| – | – |
-6,940,000
| Closed | -$164M |
|
|
ICVX
83
DELISTED
Icosavax, Inc. Common Stock
ICVX
| – | – |
-5,963,565
| Closed | -$94M |
|